Xellia acquires US production plant
Novo A/S-owned Xellia Pharmaceuticals continues to expand production capacity across the Atlantic. The company has bought a plant from a British-based drug group in a bid to facilitate further pipeline expansion in the US.
BY STEFAN SINGH KAILAY
Xellia Pharmaceuticals, which is owned by Novo A/S, continues to expand its reach in the US.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
BioPorto CFO switches to Novo-owned company
For abonnenter
Xelia buys US facilitites
For abonnenter
